Clinical Trials Browser

Phase 2 × Unknown × 177Lu-octreotide, DOTA(0)-Tyr(3)- × Clear all

NCT04194125 2020-11-04

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Phase 2 Unknown

Neuroendocrine Tumors